COMMUNICATION
|
doi:10.20944/preprints202103.0113.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
blood-based mutation burden (bTMB); cancer immunotherapy; immune checkpoint inhibitor (ICI); biomarker; mutation
Online: 2 March 2021 (21:45:40 CET)